Age-related risks of long-term oral anticoagulant therapy

Authors:
  • JGJerry H. Gurwitz
    Jerry H. Gurwitz
  • RGRobert J. Goldberg
    Robert J. Goldberg
  • AHAnn Holden
    Ann Holden
  • NKNancy Knapic
    Nancy Knapic
  • JAJack Ansell
    Jack Ansell

Abstract
• Long-term oral anticoagulant therapy is critical to the optimal management of various thromboembolic and vascular disorders. To determine whether age is related to the development of bleeding complications in patients who are receiving long-term oral anticoagulant therapy, the records of 321 patients who were followed up in the university hospital outpatient anticoagulation clinic during an eight-year period were reviewed. During this period, 61 patients (19%) developed minor bleeding complications, and 14 patients (4.4%) developed major bleeding complications. In utilizing a life-table approach to adjust for varying lengths of follow-up, the risk of initial minor bleeding complications was found to be greatest within the first three months (14%). For major bleeding complications, risk increased throughout the first two years of anticoagulation clinic follow-up, with no particular period of greatest risk. No significant differences in the risk of initial minor or major bleeding complications were observed in the various age groups that were examined (Arch Intern Med1988;148:1733-1736)

This publication has 8 references indexed in Scilit: